US Patent No. 8,936,919

Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGE-A3-marker
Jan 28, 2015

GlaxoSmithKline has been awarded US Patent No. 8,936,919, "Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGE-A3-marker."

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.